ADRIENNE CESAR: Open Payments
NPI 1265274377 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $194 · 2025 $832
Food & beverage: $832
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $228 |
| AstraZeneca Pharmaceuticals LP | 2 | $183 |
| Actelion Pharmaceuticals US, Inc. | 1 | $124 |
| Lilly USA, LLC | 1 | $115 |
| Movair Inc | 1 | $108 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| United Therapeutics Corporation | 1 | $17 |
Products named: UPTRAVI, AIRSUPRA, ZEPBOUND, LUISA, FASENRA, NUCALA, INSPIRE, Tyvaso.
Industry payments across LA — which companies pay providers there.
